No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Healthcare Information Services
Medical Data Vision Co., Ltd. specializes in the comprehensive development, production, maintenance, and sales of integrated medical information systems across Japan. The company's offerings also include medical data analysis, surveys, and consulting services, as well as management advisory for healthcare institutions. Furthermore, it provides dedicated medical data services and is involved in the conceptualization, development, and operation of various online portal platforms. Its broad client base encompasses pharmaceutical companies, medical device manufacturers, academic bodies, research organizations, and health insurance providers. Founded in 2003, the company maintains its headquarters in Tokyo, Japan.
www.mdv.co.jpNo one on the platform currently holds 3902.T.
No tracked institution reports a position in 3902.T as of their last filing.
No one on the platform has traded 3902.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 102.8% | — | — | — | ||
| Rev. Growth % | 10.7% | 7.4% | ||||
| Profit Margin % | 4.3% | 7.9% | 8.8% | |||
| Free Cash Flow Margin % | 11.0% | 10.2% | 11.2% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $8.6B | +25.5% | $19.30 | $15.89–$22.71 | — | 2 |
| 2027 | $10.5B | +22.1% | $27.70 | $22.75–$32.65 | — | 2 |
| 2028 | $9.6B | -8.9% | $24.80 | $22.49–$27.11 | — | 1 |
| 2029 | $10.5B | +9.6% | $29.10 | $26.39–$31.81 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| -0.94% |
| $7.1B |
| — |
| 4320.TCE Holdings Co., Ltd. | $1645.00 | -0.18% | $27.4B | — |
| 4575.TCanBas Co., Ltd. | $735.00 | -0.54% | $14.5B | — |
Source: Financial Modeling Prep · peers by sector/industry